Search
for
Sort by
Research 211–240 of 1000+
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- The Incidence of Alopecia Areata in a COVID-19-Vaccinated Population: A Single-Center Review
- Alopecia Areata. Current situation and perspectives
- Hair Restoration Surgery in Patients with Hypotrichosis of the Pubis
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Hair Diameter Variation in Different Vertical Regions of the Occipital Safe Donor Area
- Hair diameter evaluation in different regions of the safe donor area in Asian populations
- Contextualización histórica y social de la remoción del vello púbico femenino
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Pubic Hair Restorative Surgery Using Grafts Harvested by the Nonshaven Follicular Unit Extraction Technique
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Alopecia areata: An update
- Alopecia areata: A review
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Update on the Treatment of Alopecia Areata
- ALOPECIA AREATA-A CLINICAL ANALYSIS
- Diagnostic challenges in determining alopecia areata
- Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins
- Trichoscopy in alopecia areata and trichotillomania
- Investigating Alopecia Areata and its Connection to The High-Mobility Group Box 1: Review Article
- ALOPECIA AREATA IN INFANTS: IS IT UNCOMMON?
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Alopecia areata incognita: A Hypothesis
- Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata
- Quality of Life in Alopecia Areata: A Study of 60 Cases
- Non-scarring patchy alopecia in patients with systemic lupus erythematosus differs from that of alopecia areata